International Biotechnology Trust (IBT) is an investment trust company listed on the London Stock Exchange which invests in companies within the biotechnology sector. The portfolio aims to capture the best chances of clinical, regulatory and commercial success from a diversified portfolio of public and private biotechnology investments.

The ticker for IBT is IBT.L. The unaudited net asset value and yesterday's closing share price can be seen at the top of this page.

The Company's investment objective is to achieve long term capital growth by investing in high growth, development stage biotechnology companies that are either quoted or unquoted. IBT invests in shares of companies that are considered to be good value, with experienced management and strong potential upside through the development and/or commercialisation of a product, device or enabling technology.